Dr. Camprodon is a clinician-scientist in the Department of Psychiatry at Massachusetts General Hospital (MGH) and Harvard Medical School, where he directs the Laboratory for Neuropsychiatry and Neuromodulation and serves as Director of Translational Research in the Division of Neurotherapeutics. Clinically, he is the director of the Transcranial Magnetic Stimulation clinical service and serves as an attending physician in the departments of Neurology (Division of Behavioral Neurology) and Psychiatry (Neuropsychiatry clinics) at MGH.
His research uses multimodal combinations of neuroimaging and brain stimulation to investigate neural circuitry and plasticity in a translational manner. His laboratory works with a wide range of noninvasive and invasive neuromodulation techniques including transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT) and deep brain stimulation (DBS) among others. He also uses both functional and structural MRI, in addition to innovative combinations of TMS and tDCS with neuroimaging.
Dr. Camprodon is interested in understanding basic circuit properties of human neural networks and how maladaptive plastic changes lead to neuropsychiatric disorders. Critical efforts are geared towards applying the paradigms and methods of basic systems neuroscience to develop high-impact clinical tools, identify targets for therapeutic action and design individualized image-guided neuromodulation treatments.